Result
-€402,294 -€402,294
From profit to loss in 2025, after a profit of €7,002 in 2024.
PATHOMATION
Overview
Lifetime
13 annual accounts with figures on one time axispeak €739,917 (2023)
€568,228▼ 17.0%
lowest -€402,294 (2025)
-€402,294▼ €409,296
peak €1.3m (2024)
€890,585▼ 31.1%
€808,477▼ 40.4%
peak 7.4 FTE (2025)
7.4 FTE▲ 42.3%
Board4 names since 2021
4 directorsHISTODIG and 3 others
Owners
18.52%CellCarta
Documentsfilings and deeds
16-07-202615 days before the deadline
2025abbreviated format
Gross margin from €684,218 to €568,228Loss of €402,294Staff from 5.2 FTE to 7.4 FTEShare issue · Amendment of the articles 29-01Equity from €1.3m to €890,585Debts from €1.4m to €808,477
Key points
from the 2025 annual accountsInvestments
€645,843 1.9 × depreciation
Green is investment, beige is depreciation.
Staff
9 employees on 31-12-2025
In 2025, 4 people joined and nobody left.
Filings
13 annual accounts since 2013
The 2019 accounts came 18 days late. The other nine of the last ten were filed on time.
Board
2 joined
New directors. Latest change 24-04-2026 · 4 in office.
Position in the sector
-€402,294
Lower net result than 95% of companies in computer programming and consultancy. Sector median €22,924 · 3,405 companies.
Checked score
67
Healthy
Financially stronger than 24% of micro companies in computer programming and consultancy (NACE 62)
Probability in this band: 0.55% to 1.5%
Bankruptcy probability within 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.1% across 25,932 companies (NACE 62, micro).
About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.2%▲ +0.1 percentage points vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.3%▲ +0.1 percentage points vs 06-2025
08-2025: 0.1%▼ -0.2 percentage points vs 07-2025lowest value
09-2025: 0.1%● unchanged vs 08-2025lowest value
10-2025: 0.1%● unchanged vs 09-2025lowest value
11-2025: 0.1%● unchanged vs 10-2025lowest value
12-2025: 0.1%● unchanged vs 11-2025lowest value
01-2026: 0.1%● unchanged vs 12-2025lowest value
02-2026: 0.1%● unchanged vs 01-2026lowest value
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.8%▲ +0.7 percentage points vs 07-2026highest value
09-2026: 0.8%● unchanged vs 08-2026highest value
10-2026: 0.8%● unchanged vs 09-2026highest value
11-2026: 0.8%● unchanged vs 10-2026highest value
Financial strengthWeak
Score breakdown
raises risk
Loss of €402,294 (financial year 2025)
Size: 7.4 FTE, total assets €1.7m
lowers risk
Equity €890,585 (52.4% of total assets)
Sector: Computer programming, consultancy and related activities (NACE 62)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 62, micro). It does better than 45% of them on solvency, 25% on liquidity, 5% on profitability and 20% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 4,805 companies had the same profile as PATHOMATION has now. Each dot stands for 13 companies, two years later.
88.1%
were still trading
9.8%
stopped another way
2.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of PATHOMATION itself: 0.8% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 4,805 companies, not a prediction for PATHOMATION. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.29 (1.72 in 2024), below the usual 1.5. Short-term debt is 23.1% and cash 6.4% of total assets. 47.6% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
15 days early
2024
20 days early
2023
58 days early
2022
25 days early
2021
61 days early
2020
37 days early
2019
18 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 28 days before the deadline. In the sector (NACE 62), the median for financial year 2024 was 9 days before the deadline, and 33% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 July (4 of the last 5 accounts filed within 32 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
H
HISTODIG
Director, Wim Waelput
KC
KOCKX-CONSULTING
Director, Mark Kockx
HT
Heitbrink Teixidor SL
Director, since 24-04-2026
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0500694204
Share issue · Amendment of the articles
Issue of 72,000 shares · Gazette deed
2 directors appointed, 2 resignations
Resignations: HISTODIG and KOCKX-CONSULTING · Appointments: HISTODIG (director) and KOCKX-CONSULTING (director) · Permanent representatives: Wim Waelput and Mark Kockx · General meeting of 20-12-2023 · Gazette deed
Registered office moved from Sint-Niklaas to Wilrijk
New registered office: Sint-Bavostraat 78-80, 2610 Wilrijk · Previous registered office: Raoul Steppestraat 1, 9100 Sint-Niklaas · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PATHOMATION Antwerp | €1.7m | €568,228 | 52.4% | 7.4 |
| We Solve It Willebroek | €1.3m | €500,153 | 14.7% | 5.4 |
| DE VOS Systems Antwerp | €2.2m | €605,970 | 45.6% | 5.2 |
| Emixa Industry Solutions Antwerp | €1.9m | €600,631 | -17.2% | 6.1 |
| SPEARPOINT Rijkevorsel | €1.7m | €648,881 | -10.2% | 12.8 |
| APPMAX Genk | €1.2m | €504,074 | 42.3% | 7.7 |
| WEBFORCE BENELUX Anderlecht | €1.5m | €751,380 | 46.5% | 7.6 |
These companies have the same main activity as PATHOMATION: computer programming (NACE 62100). They are comparable in size and age: total assets between €1.2m and €2.2m, founded between 2006 and 2015.
Official details
Source: KBO- Status
- Active since 08-11-2012Normal situation
- Activity
- Computer programmingNACE 62100and 1 other
- Joint committee
- 200Auxiliary committee for white-collar workers · annual accounts 2025
- Establishment unit
- 2.215.005.1932610 Antwerp, since 08-11-2012
- Financial year end
- 31 December
- Peppol
- Reachable since 04-04-2025
Annual accounts 2025
- €568,228▼ 17.0%
- ≈ €1.5mestimated
- €402,294
- €890,585▼ 31.1%
- €1.7m▼ 35.8%
- Employeeson 31-12-2025
- 9▲ 80.0%
- Filing
- Filed on 16-07-2026, 15 days before the end of the filing period
Insights on PATHOMATION
PATHOMATION files the abbreviated format. That format states no turnover. The gross margin rose from -€17,234 in 2013 to €568,228 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
abbreviated format, filed on 16-07-2026, 15 days before the deadline€568,228
▼ 17.0%
-€387,438
▼ €409,636
-€402,294
▼ €409,296
€115,091
▼ 84.5%
52.4%
▲ 3.6 percentage points
1.29
▼ 0.43
Turnover and EBIT margin are not published. The abbreviated or micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €1.5m. Estimated: probably between €1.0m and €2.4m.
Balance sheet
balance sheet total €1.7m on 31-12-2025What the company ownsHow it is paid for
in €m
in euro
Position in the sector
52.4%
Higher than 55% of 3,405 companies in 2025.
1.29
Higher than 35% of 3,266 companies in 2025.
-23.7%
Higher than 10% of 3,314 companies in 2025.
PATHOMATION
Middle half of the sector
80% of the sector
Abbreviated accounts in computer programming and consultancy (NACE 62)
Net result: bottom quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: middle half · Staff: middle half
Staff
€83,438
Staff costs divided by the average number of full-time equivalents.
+4 people
people who joined
people who left
In 2025, 4 people joined and nobody left. Training hours in 2025: 114.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||||||||||
20/58 |
1.7m | 2.6m | 1.1m | 918,216 | 846,521 | 581,560 | 431,164 | 323,024 | 256,256 | 209,653 | 118,227 | 91,661 | 71,061 | |
21/28 |
1.2m | 882,032 | 688,899 | 555,723 | 419,472 | 358,520 | 305,107 | 204,569 | 86,508 | 82,278 | 81,552 | 72,056 | 55,091 | |
21 |
1.2m | 877,383 | 682,552 | 543,810 | 411,124 | 357,520 | 294,828 | 180,838 | 80,162 | 81,302 | 79,432 | 68,790 | 50,681 | |
22/27 |
19,337 | 3,648 | 5,347 | 10,913 | 7,348 | 0 | 10,279 | 23,731 | 6,347 | 976 | 2,121 | 3,265 | 4,410 | |
22 |
- | - | - | 3,397 | - | - | - | - | - | - | - | - | - | |
24 |
17,082 | 1,013 | 2,331 | 7,516 | 3,570 | 0 | 10,279 | 23,731 | 6,347 | 976 | 2,121 | 3,265 | 4,410 | |
26 |
2,254 | 2,635 | 3,016 | - | 3,778 | - | - | - | - | - | - | - | - | |
28 |
1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | - | - | - | - | - | - | - | |
29/58 |
507,432 | 1.8m | 363,140 | 362,493 | 427,050 | 223,039 | 126,057 | 118,455 | 169,747 | 127,375 | 36,675 | 19,606 | 15,970 | |
40/41 |
373,548 | 842,877 | 308,701 | 324,641 | 279,441 | 95,370 | 96,737 | 109,973 | 141,474 | 122,015 | 31,574 | 9,253 | 3,424 | |
40 |
342,962 | 830,626 | 308,694 | 271,181 | 224,248 | 83,690 | 91,667 | 108,862 | 141,171 | 122,015 | 30,605 | 6,292 | 1,568 | |
41 |
30,586 | 12,251 | 7 | 53,460 | 55,192 | 11,680 | 5,070 | 1,111 | 303 | - | 969 | 2,961 | 1,856 | |
54/58 |
109,401 | 912,228 | 40,518 | 30,552 | 146,225 | 127,670 | 21,830 | - | 28,273 | 5,360 | 5,101 | 10,352 | 12,546 | |
490/1 |
24,483 | 11,280 | 13,921 | 7,300 | 1,383 | 0 | 7,490 | 8,482 | - | - | - | - | - | |
| Balance sheet: equity and liabilities | ||||||||||||||
10/49 |
1.7m | 2.6m | 1.1m | 918,216 | 846,521 | 581,560 | 431,164 | 323,024 | 256,256 | 209,653 | 118,227 | 91,661 | 71,061 | |
10/15 |
890,585 | 1.3m | 485,957 | 380,816 | 505,980 | 284,426 | 208,850 | 113,202 | 96,611 | 75,551 | 7,469 | 21,511 | 69,204 | |
10/11 |
889,920 | 889,920 | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | |
100 |
- | - | - | - | - | - | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | 90,000 | |
13 |
665 | 402,959 | 395,957 | 290,816 | 415,980 | 194,426 | 118,850 | 23,202 | 6,611 | - | - | - | - | |
130/1 |
- | 0 | 9,000 | 9,000 | 9,000 | 9,000 | - | - | - | - | - | - | - | |
130 |
- | - | - | - | - | - | 9,000 | 4,302 | 2,500 | - | - | - | - | |
1311 |
- | 0 | 9,000 | 9,000 | 9,000 | 9,000 | - | - | - | - | - | - | - | |
133 |
665 | 402,959 | 386,957 | 281,816 | 406,980 | 185,426 | 109,850 | 18,900 | 4,111 | - | - | - | - | |
14 |
- | - | - | - | 0 | - | - | - | - | -14,449 | -82,531 | -68,489 | -20,796 | |
17/49 |
808,477 | 1.4m | 566,082 | 537,401 | 340,542 | 297,134 | 222,314 | 209,822 | 159,645 | 134,102 | 110,758 | 70,150 | 1,857 | |
17 |
89,181 | 109,948 | 105,125 | 139,727 | 20,000 | 120,000 | 20,000 | 100,000 | 60,000 | 100,000 | 99,500 | 59,500 | - | |
170/4 |
89,181 | 109,948 | 105,125 | 139,727 | 20,000 | 120,000 | 20,000 | 100,000 | 60,000 | 100,000 | 99,500 | 59,500 | - | |
42/48 |
392,341 | 1.0m | 302,136 | 274,585 | 318,061 | 175,453 | 167,907 | 69,953 | 70,976 | 27,792 | 7,422 | 9,654 | 1,857 | |
42 |
20,767 | 101,435 | 19,603 | 19,045 | 100,000 | - | - | - | - | - | - | - | - | |
43 |
6,233 | - | - | - | - | - | 0 | 2,677 | - | - | - | - | - | |
430/8 |
6,233 | - | - | - | - | - | 0 | 2,677 | - | - | - | - | - | |
44 |
78,646 | 519,876 | 96,591 | 99,963 | 34,690 | 2,691 | 5,980 | 17,738 | 6,549 | 6,090 | 377 | 6,285 | 1,857 | |
440/4 |
78,646 | 519,876 | 96,591 | 99,963 | 34,690 | 2,691 | 5,980 | 17,738 | 6,549 | 6,090 | 377 | 6,285 | 1,857 | |
45 |
66,481 | 54,910 | 45,943 | 45,577 | 26,467 | 25,583 | 22,800 | 26,469 | 46,835 | 21,701 | 5,978 | 3,369 | - | |
450/3 |
13,338 | 15,503 | 12,935 | 4,351 | 7,833 | 12,719 | 13,745 | 19,099 | 34,711 | 13,310 | 1,691 | 585 | - | |
454/9 |
53,143 | 39,406 | 33,007 | 41,226 | 18,634 | 12,863 | 9,056 | 7,369 | 12,124 | 8,391 | 4,286 | 2,785 | - | |
47/48 |
220,214 | 347,828 | 140,000 | 110,000 | 156,904 | 147,179 | 139,126 | 23,069 | 17,592 | - | 1,068 | - | - | |
492/3 |
326,954 | 221,542 | 158,821 | 123,088 | 2,481 | 1,681 | 34,407 | 39,869 | 28,669 | 6,310 | 3,836 | 996 | - | |
| Income statement | ||||||||||||||
9900 |
568,228 | 684,218 | 739,917 | 445,114 | 610,424 | 347,062 | 355,439 | 193,002 | 175,540 | 162,300 | 56,346 | -1,627 | -17,234 | |
62 |
617,444 | 409,999 | 409,038 | 378,507 | 161,528 | 109,616 | 74,178 | 67,733 | 80,665 | 58,738 | 41,631 | 26,112 | - | |
630 |
336,246 | 250,467 | 211,219 | 185,333 | 138,558 | 119,122 | 111,360 | 86,177 | 42,194 | 31,809 | 25,302 | 18,342 | 2,242 | |
640/8 |
1,977 | 1,554 | 1,452 | 507 | 348 | 552 | 3,372 | 478 | 642 | 840 | 441 | 440 | 1,025 | |
9901 |
-387,438 | 22,198 | 118,209 | -119,233 | 309,991 | 117,772 | 166,528 | 38,613 | 52,039 | 70,913 | -11,028 | -46,521 | -20,500 | |
75/76B |
592 | 208 | 40 | 783 | 382 | 5,374 | 1,795 | - | 1 | 12 | 21 | 50 | 13 | |
75 |
592 | 208 | 40 | 783 | 382 | 5,374 | 1,795 | - | 1 | 12 | 21 | 50 | 13 | |
65/66B |
15,283 | 9,155 | 8,907 | 6,562 | 5,528 | 6,043 | 11,381 | 2,343 | 2,180 | 2,843 | 3,050 | 1,211 | 306 | |
65 |
15,283 | 9,155 | 8,907 | 6,562 | 5,528 | 6,043 | 11,381 | 2,343 | 2,180 | 2,843 | 3,050 | 1,211 | 306 | |
9903 |
-402,129 | 13,251 | 109,342 | -125,012 | 304,845 | 117,103 | 156,942 | 36,271 | 49,860 | 68,082 | -14,057 | -47,681 | -20,793 | |
67/77 |
165 | 6,249 | 4,201 | 152 | 36,388 | 11,225 | 35,794 | 230 | 12,800 | - | -15 | 13 | 3 | |
9904 |
-402,294 | 7,002 | 105,141 | -125,164 | 268,458 | 105,878 | 121,148 | 36,041 | 37,060 | 68,082 | -14,042 | -47,694 | -20,796 | |
9905 |
-402,294 | 7,002 | 105,141 | -125,164 | 268,458 | 105,878 | 121,148 | 36,041 | 37,060 | 68,082 | -14,042 | -47,694 | -20,796 | |
| Appropriation of the result | ||||||||||||||
9906 |
-402,294 | 7,002 | 105,141 | -125,164 | 268,458 | 105,878 | 121,148 | 36,041 | 22,611 | -14,449 | -82,531 | -68,489 | -20,796 | |
791/2 |
402,294 | - | 0 | 125,164 | - | - | - | - | - | - | - | - | - | |
691/2 |
0 | 7,002 | 105,141 | - | 221,554 | 75,576 | 95,648 | 16,591 | 6,611 | - | - | - | - | |
6920 |
- | - | - | - | - | 0 | 4,698 | 1,802 | 2,500 | - | - | - | - | |
6921 |
0 | 7,002 | 105,141 | - | 221,554 | 75,576 | 90,950 | 14,789 | 4,111 | - | - | - | - | |
694/7 |
- | - | - | - | 46,904 | 30,302 | 25,500 | 19,450 | 16,000 | - | - | - | - | |
696 |
- | - | - | - | 46,904 | 30,302 | 25,500 | 19,450 | 16,000 | - | - | - | - | |
| Social balance sheet | ||||||||||||||
9087 |
7.4 | 5.2 | 4.9 | 4.8 | 3 | 1.6 | 1 | 0.8 | 0.7 | 0.6 | 1 | 1 | - | |
Hours worked1013 |
12,562 | 8,733 | 8,346 | 8,419 | 4,642 | 3,165 | 1,740 | 1,482 | 1,256 | 1,166 | 821 | 517 | - | |
| Document | ||||||||||||||
The notes to these accounts have 21 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 16-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | abbreviated format | 16-07-2026 | 2026-00303895 | |
| 31-12-2024 | abbreviated format | 11-07-2025 | 2025-00264655 | |
| 31-12-2023 | abbreviated format | 03-06-2024 | 2024-00110199 | |
| 31-12-2022 | abbreviated format | 06-07-2023 | 2023-00228395 | |
| 31-12-2021 | micro format | 31-05-2022 | 2022-20039404 | |
| 31-12-2020 | micro format | 24-06-2021 | 2021-25100076 | |
| 31-12-2019 | micro format | 18-08-2020 | 2020-42500085 | |
| 31-12-2018 | micro format | 14-05-2019 | 2019-13200121 | |
| 31-12-2017 | micro format | 20-07-2018 | 2018-37000577 | |
| 31-12-2016 | micro format | 10-07-2017 | 2017-30400348 | |
| 31-12-2015 | abbreviated format | 17-06-2016 | 2016-19500006 | |
| 31-12-2014 | abbreviated format | 17-07-2015 | 2015-33000337 | |
| 31-12-2013 | abbreviated format | 14-07-2014 | 2014-29900287 |
Subsidies and aid
Flemish government 2022 to 2025, 15 entries, €295,986 awarded, €217,020 paid
| Year | Entries | Awarded | Paid |
|---|---|---|---|
| 2025 | 6 | €66,660 | €37,011 |
| 2024 | 4 | €10,578 | €89,556 |
| 2023 | 4 | €215,613 | €87,318 |
| 2022 | 1 | €3,135 | €3,135 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -51,193 | 272,665 | 329,428 | 66,100 | 448,549 | 236,894 | 277,888 | 124,791 | 94,233 | 102,722 | 14,274 | -28,178 | -18,259 | ||
| -66,049 | 257,469 | 316,360 | 60,169 | 407,015 | 224,999 | 232,508 | 122,218 | 79,254 | 99,891 | 11,260 | -29,351 | -18,554 | ||
| 645,843 | 443,600 | 346,194 | 321,744 | 199,509 | 172,535 | 211,898 | 204,238 | 46,425 | 32,534 | 34,799 | 35,307 | 56,404 | ||
| -802,827 | 871,711 | 9,966 | -115,674 | 18,556 | 105,839 | - | - | 22,913 | 259 | -5,251 | -2,194 | - | ||
| 115,091 | 742,337 | 61,003 | 87,908 | 108,989 | 47,587 | -41,850 | 48,502 | 98,771 | 99,583 | 29,252 | 9,951 | 14,113 | ||
| 52.4% | 48.8% | 46.2% | 41.5% | 59.8% | 48.9% | 48.4% | 35.0% | 37.7% | 36.0% | 6.3% | 23.5% | 97.4% | ||
| 1.29 | 1.72 | 1.20 | 1.32 | 1.34 | 1.27 | 0.75 | 1.69 | 2.39 | 4.58 | 4.94 | 2.03 | 8.60 | ||
| 0.91 | 1.05 | 1.16 | 1.41 | 0.67 | 1.04 | 1.06 | 1.85 | 1.65 | 1.77 | 14.83 | 3.26 | 0.03 | ||
| -45.2% | 0.5% | 21.6% | -32.9% | 53.1% | 37.2% | 58.0% | 31.8% | 38.4% | 90.1% | -188.0% | -221.7% | -30.0% | ||
| -23.7% | 0.3% | 10.0% | -13.6% | 31.7% | 18.2% | 28.1% | 11.2% | 14.5% | 32.5% | -11.9% | -52.0% | -29.3% | ||
| -3.35 | 29.78 | 36.99 | 10.07 | 81.15 | - | - | - | - | - | - | - | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Social balance sheet
| Item | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Employees at the balance-sheet date | 9 | 5 | 5 | 6 | 4 |
| full-time | 9 | 5 | 4 | 3 | 1 |
| part-time | 0 | 0 | 1 | 3 | 3 |
| in full-time equivalents | 9 | 5 | 4.8 | 4.9 | 3.1 |
| 7.4 | 5.2 | 4.9 | 4.8 | 2.6 | |
| On a permanent contract | 9 | 5 | 5 | 6 | 4 |
| Joined | 4 | 1 | 1 | 4 | 1 |
| Left | 0 | 1 | 2 | 2 | 0 |
| Training hours | 114 | 64 | - | 95 | - |
Source: social balance sheet in the 2021 to 2025 annual accounts
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | €19,320 | €1,397 | €0 | €7,250 | €8,516 |
| Intangible fixed assets | €626,523 | €442,202 | €346,194 | €314,495 | €190,994 |
| Financial fixed assets | €0 | - | - | - | - |
| €336,246 | €250,467 | €211,219 | €185,333 | €138,558 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on PATHOMATION
The operating result for 2025 is a loss of €387,438, after a profit of €22,198 in 2024. It is the lowest result since 2013.
Debt's share of the balance-sheet total falls from 51.2% to 47.6%. Equity and debt are lower.
Board & ownership
Board
4 directors, last change in 2024HISTODIG
Director (not named in the articles), permanent representative Wim Waelput
appointed by deed of 08-01-2024
term without a fixed end
earlier director, until 08-01-2024
listed in the 2025 annual accounts, filed on 16-07-2026
KOCKX-CONSULTING
Director (not named in the articles), permanent representative Mark Kockx
appointed by deed of 08-01-2024
term without a fixed end
earlier director, until 08-01-2024
Heitbrink Teixidor SL
Director
since 24-04-2026
listed in the 2025 annual accounts, filed on 16-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 08-01-2024
Permanent representatives 2
Mandates through the years
4 names, the dashed line is todayHISTODIG
Director (not named in the articles)
Director (not named in the articles)
KOCKX-CONSULTING
Director (not named in the articles)
Director (not named in the articles)
CellCarta NV
Director
Director
Heitbrink Teixidor SL
Director
Director
BoardEarliermandate already running before its first mention
Mandates as a list
- HISTODIG
- Director (not named in the articles), since before 31-12-2021
- Director, until 08-01-2024
- KOCKX-CONSULTING
- Director (not named in the articles), since before 31-12-2021
- Director, until 08-01-2024
- CellCarta NV
- Director, since before 31-12-2025
- Heitbrink Teixidor SL
- Director, since before 31-12-2025
Control
Shareholder
Equity €25.9m
Profit €7.7m in 2025 (profit €8.8m in 2024)
Checked score 96
Source: accounts CellCarta 2025
18.52%
This company
PATHOMATION
Equity €890,585
Loss €402,294 in 2025
Capital
- Contribution
- €889,920
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- CellCarta
Source: lists of holdings in the owners' accounts
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- 3 directors“Maximum zes(6)jaar,onbeperkt hernieuwbaar, gedelegeerd bestuurder”deed of 29-01-2025 (in Dutch)
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Investerings-en Aandeelhoudersovereenkomst”deed of 29-01-2025 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 10:00deed of 08-01-2024 (in Dutch)
Network & group
No group
PATHOMATION has no parent and no holdings in its annual accounts.
Connections & network
4 current directorsThe network starts from the directors of PATHOMATION. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Timeline
31 events since 2012Board
Capital
Filings
Financial
Establishments
Address
20122014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 15 days before the deadline
2025
Weakest financial year net -€402,294 The net result drops to -€402,294, the lowest from 2013 to 2025.
Annual accounts 2024 filed PDFabbreviated format · 20 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0500694204
Share issue · Amendment of the articlesIssue of 72,000 shares1 point ▸
- Amendment of the articles, article 5
- The deed holds 5 more points.
2024
Equity above €1m equity €1.3m ▲166% After 2 profitable years in a row, equity reaches €1.3m.
Annual accounts 2023 filed PDFabbreviated format · 58 days before the deadline
2 directors appointed, 2 resignationsResignations: HISTODIG and KOCKX-CONSULTING · Appointments: HISTODIG (director) and KOCKX-CONSULTING (director) · Permanent representatives: Wim Waelput and Mark Kockx · General meeting of 20-12-202314 points ▸
- 90 shares
- Director resignation, HISTODIG
- Director resignation, KOCKX-CONSULTING
- Board rule, 2
- Director appointment, HISTODIG (director (not named in the articles))
- Director appointment, KOCKX-CONSULTING (director (not named in the articles))
- Permanent representative, Wim Waelput
- Permanent representative, Mark Kockx
- Registered office clause, Prinses Josephine Charlottelaan 10, 2600 Antwerpen (Berchem)
- General meeting, 20-12-2023
- Purpose change, “gewijzigd voorwerp zoals aangenomen in nieuwe statuten” (deed in Dutch)
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- Director discharge, HISTODIG
- Director discharge, KOCKX-CONSULTING
- The deed holds 5 more points.
2023
Back to profit net €105,141 The net result is €105,141, after one loss-making year.
Annual accounts 2022 filed PDFabbreviated format · 25 days before the deadline
Power of attorney: Rudy HovelinckBoard meeting of 18-02-20232 points ▸
- Board meeting, 18-02-2023
- Power of attorney, Rudy Hovelinck, mentioned twice in the deed
Power of attorney: Yves SucaetBoard meeting of 07-12-20222 points ▸
- Board meeting, 07-12-2022
- Power of attorney, Yves Sucaet, mentioned 3 times in the deed
- The deed holds 1 more point.
2022
Annual accounts 2021 filed PDFmicro format · 61 days before the deadline
2021
Highest result from 2013 to 2025 net €268,458 ▲154% The operating result of €309,991 and the net result of €268,458 are both a record.
Equity above €500,000 equity €505,980 ▲77.9% After 6 profitable years in a row, equity reaches €505,980.
Annual accounts 2020 filed PDFmicro format · 37 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 18 days late
Power of attorney: Yves SucaetBoard meeting of 21-04-20202 points ▸
- Board meeting, 21-04-2020
- Power of attorney, Yves Sucaet, mentioned twice in the deed
Registered office moved from Sint-Niklaas to WilrijkNew registered office: Sint-Bavostraat 78-80, 2610 Wilrijk · Previous registered office: Raoul Steppestraat 1, 9100 Sint-Niklaas1 point ▸
- Registered-office move, Sint-Bavostraat 78-80, 2610 Wilrijk
2019
Equity above €200,000 equity €208,850 ▲84.5% After 4 profitable years in a row, equity reaches €208,850.
Annual accounts 2018 filed PDFmicro format · 78 days before the deadline
2018
Equity above €100,000 equity €113,202 ▲17.2% After 3 profitable years in a row, equity reaches €113,202.
Annual accounts 2017 filed PDFmicro format · 11 days before the deadline
2017
Annual accounts 2016 filed PDFmicro format · 21 days before the deadline
2016
Back to profit net €68,082 The net result is €68,082, after 3 loss-making years.
Annual accounts 2015 filed PDFabbreviated format · 44 days before the deadline
2015
Liquidity more than doubled current ratio 4.94 The current ratio rises from 2.03 to 4.94. Short-term debt falls from €9,654 to €7,422.
Annual accounts 2014 filed PDFabbreviated format · 14 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 17 days before the deadline
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 0500.694.204
- VAT number
- BE 0500.694.204
- Peppol ID
- 0208:0500694204
- Other Peppol ID
- 9925:BE0500694204
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 08-11-2012
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 10:00deed of 08-01-2024 (in Dutch)
- Peppol
- Reachable since 04-04-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- PATHOMATION in Dutch
- Entity type
- Legal entity
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Vlaams Gewest”deed of 08-01-2024 (in Dutch)
Activities
NACEBEL 2025VAT activities
62100
Computer programming main activity
Social security (RSZ) activities
62100
Computer programming main activity
Joint committees annual accounts 2025
JC 200
Auxiliary committee for white-collar workers
Codes under NACEBEL 2008
VAT activities
62010
Computer programming, consultancy and related activities main activity
62020
IT consultancy
Social security (RSZ) activities
62010
Computer programming, consultancy and related activities main activity
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Prinses Joséphine Charlottelaan 10 registered office 2600 Antwerp | ||
| PATHOMATION BVBA Sint-Bavostraat 78-80, 2610 Antwerp | 08-11-2012 | 2.215.005.193 |
2 former offices
- Sint-Bavostraat 78-80, 2610 Antwerpen until the deed of 08-01-2024
- Raoul Steppestraat 1, 9100 Sint-Niklaas until 01-02-2020 · deed of 27-02-2020
Buildings and parcels at the addresses
- Ground area
- 4,893 m²
- Buildings
- 1,125 m²
- Volume, LiDAR
- 5,679 m³
- Tallest building
- 9.3 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 11051C0160/00L006 | 4,612 m² | 1 · 972 m² | 9.3 m · 2 |
| 11303C0294/00N007 | 281 m² | 1 · 152 m² | 9.1 m · 3 |